In this conversation, I cover the emerging science on psychedelics. Not the hype, but the data.
How these compounds interact with the brain, reopen windows of neuroplasticity, and appear to influence aging, neurodegenerative disease, mental health, trauma, and resilience in ways we’re only beginning to understand.
I walk through studies looking at psychedelics in neurodegenerative disease, stroke recovery, and end-of-life care, specifically improvements in Parkinson’s, life extension in cells and mice, and cancer patients losing their fear of death.
The thread tying all of this together is simple but uncomfortable: longevity isn’t just about adding years to the body. It’s about tending to the nervous system, the mind, and the stories we carry.
If we want to live longer and better, we may need to stop treating biology and psychology as separate systems, and start designing a more integrated, humane approach to aging.
Timestamps:
00:00 Introduction to Epigenetics and Longevity
02:42 The Intersection of Psychedelics and Longevity
05:36 Understanding the Hallmarks of Aging
08:51 Mental Health, Neuroplasticity, and Aging
11:45 Psychedelics and Neurodegenerative Diseases
14:46 Psychedelics in Stroke Recovery
17:33 Psychedelics and Trauma Healing
20:30 Psychedelics in End-of-Life Care
23:41 The Future of Longevity and Psychedelics
CONNECT WITH NINA’S NOTES
Newsletter: https://www.ninasnotes.xyz
LinkedIn: https://www.linkedin.com/in/ninapatrick/
Website: https://www.ninapatrick.xyz
